Press releases
Genoskin joins 3R In Vitro Testing Platform IVTIP
Genoskin joins 3R In Vitro Testing Platform Genoskin is proud to join the In Vitro Testing Industrial Platform. The IVTIP Platform was founded in 1993 and currently comprises 46 companies from different sectors (assay developers, technology providers, chemical, pharmaceutical and cosmetics companies). All members have significant in vitro testing activities. Most of the IVTIP member companies are from Europe, but IVTIP also has members in
Genoskin supported by national and local fundings to innovate in skin cancer models
The State and the Urban Community of Toulouse city launched on 15 March 2013, the first Call for collaborative research and development projects in 2013 OncoSan’Tech on all areas of innovation in relation to cancer.
Genoskin develops and markets innovative testing tools to study the effects of pharmaceutical, cosmetic and chemical products on real, live ex vivo human skin.
